U.S. drugmakers and biotechs have come to rely on Chinese partners. Now, some of them are looking for alternatives as geopolitical tensions rise.
U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners
Related Posts
The long trend of falling corporate taxes is being reversed
December 22, 2024
5:12 am
Volkswagen and Unions Enter Fourth Day of Talks
December 22, 2024
4:31 am
Oysters recalled in 3 Canadian provinces over norovirus concerns | Globalnews.ca
December 22, 2024
12:23 am